Chatham Capital Group’s Vital Farms VITL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$747K Sell
64,251
-29,982
-32% -$334K 0.1% 143
2026
Q1
$1.33M Buy
94,233
+22,238
+31% +$526K 0.19% 113
2025
Q4
$2.3M Buy
71,995
+1,020
+1% +$35.9K 0.33% 83
2025
Q3
$2.92M Sell
70,975
-580
-0.8% -$25.2K 0.42% 74
2025
Q2
$2.76M Sell
71,555
-420
-0.6% -$14.2K 0.42% 74
2025
Q1
$2.19M Buy
71,975
+3,260
+5% +$117K 0.37% 83
2024
Q4
$2.59M Buy
+68,715
New +$2.44M 0.43% 73

Other funds holding VITL

Chatham Capital Group's VITL Position: Q2 2026 in Review

Chatham Capital Group reduced its Vital Farms (VITL) stake by 32% in Q2 2026, selling an estimated $334K and leaving 64,251 shares worth $747K. The position accounts for 0.1% of the portfolio, ranked #143.

Chatham Capital Group first reported a position in VITL in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.92M in Q3 2025. 14 funds tracked by Wall St. Rank hold VITL as of Q2 2026.

  • Chatham Capital Group held 64,251 shares of Vital Farms worth $747K as of Q2 2026.
  • Chatham Capital Group sold 29,982 Vital Farms shares in Q2 2026, an estimated $334K.
  • Vital Farms made up 0.1% of Chatham Capital Group's portfolio in Q2 2026, its #143 holding.
  • Chatham Capital Group first reported a position in Vital Farms in Q4 2024 and has held it in 7 quarters since.
  • Chatham Capital Group's Vital Farms position peaked at $2.92M in Q3 2025.
  • 14 funds tracked by Wall St. Rank held Vital Farms as of Q2 2026.

Based on Chatham Capital Group's 13F filing for Q2 2026, filed 13 Jul 2026.